PUBLIC CONTRACT · 2013

Medicamentos Flumazenilo, Fluresceina,Furosemida, Glucagom, Gluconato de calcio, Heparina Sódica, Insulina Humana/Isofanica e Lipro, Naloxona

Contract value
€49,890.52
Signed on
27 February 2013
Procedure
Direct award, general (Ajuste Direto Regime Geral)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 813883

PUBLISHED DESCRIPTION

AC261/2013

WHO CONTRACTED

Parties involved

Place of performance
Portugal, Faro, Faro
NUTS region
Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
Hospira · Tax ID 502918098
Awardee
Sanofi Aventis · Tax ID 500134960
Awardee
Hikma , S.A. · Tax ID 502266791
Awardee
Novo Nordisk · Tax ID 501485210
Awardee
B.Braun Medical · Tax ID 501506543
Awardee
Labesfal · Tax ID 501169580

HOW MUCH AND WHEN

Values and timeline

Contract price
€49,890.52
Procedure base price
€0.00
Total effective price
Not reported on Portal BASE
Publication date
19 August 2013
Award date
27 February 2013
Signing date
27 February 2013
Performance period
307 days

The contract price is the value agreed in the contract, not the amount paid.

HOW IT WAS CONTRACTED

Procedure and framework

Contract type
Aquisição de bens móveis
Award criterion
Not stated
CPV code
33690000-3 - Medicamentos vários
Legal basis
Artigo 20.º, n.º 1, alínea a) do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos (DL 18/2008)
Framework agreement
Not stated
Centralised procedure
No
Environmental criterion
No
Notice
Not stated
Procedure identifier
546747

KEEP EXPLORING

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts